[ad_1]
It is estimated that in Thailand, there are about 2.2 to 3 million chronic hepatitis B patients with chronic hepatitis C infection. 300,000 to 700,000. Free testing for hepatitis B and C is available from 31 July to 3 August 2018
(23 July 2018) in the Department of Disease Control, Sombat Tanprasert. The Department of Disease Control, with Dr. Wattana Sukpaisan President of the Thai Association of Liver Diseases and Associate Professor Chantha Pipat Director of Primary Care Support System The National Office of Health Security (NHSO) jointly organized a press conference on the global campaign against hepatitis "Early detection of liver cancer far"
Dr. Sombat said that the Ministry of Public Health. Focus on hepatitis Due to cirrhosis and liver cancer. Cancer is common among Thais. There are five types of hepatitis, including types A, D and E, but the public health problem in Thailand is hepatitis B and C. It is estimated that in Thailand there is will have about 2.2 to 3 million patients with chronic hepatitis B with chronic hepatitis C. 300 000-700 000
For chronic hepatitis C Thailand has taken preventive measures. Since 2013, the Thai government has provided approximately 3,000 patients annually for the supply of pegylated interferon and ribavirin, but this drug is only effective in 60-80% of cases. Week and have high side effects. The Ministry of Public Health The National Health Insurance Network and the Network aim to provide direct-acting antivirals (DAAs), such as Sofosbuvir, Ledipasvir and Velpatasvir, for more than 90%. It takes about 12 weeks for treatment and in 2018, the National Drug Board has developed some drugs in DAAs for the treatment of patients with hepatitis C in the national pill
. The slogan is "fast-track hepatocellular carcinoma" and people are invited to receive free testing for hepatitis B and C. From July 31 to August 3, 2018 in 83 participating hospitals under the Ministry of Health in all provinces of the country (list of 83 participating hospitals https://goo.gl/QZ8Wjb) For more information, call Department of Disease Control Tel .: 1422
The teacher. Dr. Wattana said that the situation in Thailand has an estimated incidence of hepatitis B virus 5-8%, and 1-2% in the northeastern and the north
. The World Health Organization has established a policy for all countries of the world to work together to eliminate the virus in 2030 (2030), which Thailand has signed for cooperation. But the problem the world faces is that people do not know themselves or are not infected. Because these infections have no symptoms. In Thailand too. The infected person does not realize that she is. This is the cause of the infection. At present, the highest mortality rate in Thailand is malignancy, with males at the forefront, males ranked third in the Northeast, and Northeast ranked first among males and females
. Many people never realize that they have risk factors in their body. Hepatitis B and C are needed for screening. Especially the population at risk. Such as
– who received blood before the year
– Persons with a family history of liver cancer
– Persons in prison
– Persons who have been contaminated with blood or blood blood products such as tattooing, pregnant women, etc.
– People in prison
Use of narcotics
when chronic hepatitis is known. He went into the healing process. The government provides free treatment to all funds. If everyone is continually aware and tested for infection, he quickly goes into treatment. Thailand has been able to completely eliminate hepatitis over the next 12 years.
During the 2018 financial year, the NHSO defined benefits and produced additional drugs for the treatment of patients with chronic hepatitis C virus. In the universal coverage system is increased by two more 1. Sofosbuvir 400 mg tablets to take with the injection. Peginterferon Ribavirin for the treatment of chronic infections of hepatitis C, 3 and 2. Sofosbuvir 400 mg and Ledipasvir 90 mg tablets for the treatment of other chronic infections of hepatitis C with or without hypopigmentation. Cirrhosis with
This drug has been added. It can reduce the duration of treatment from 24 weeks to 12 weeks and has a better therapeutic effect than the injection. Peginterferon and Ribavirin are the same formulations. The NHS has collaborated with the Rajavithi Hospital Service Network and the Pharmaceutical Organization. The supply and distribution to the unit as of April 2018, the total value of 66,360,000 tablets, which is the national drug. During the 2016 fiscal year, the NHS has prepared a budget. Provide a vaccine against hepatitis B in total 155 642 500 baht and prepare a budget for the treatment of hepatitis C virus. A total of 230 555 250 baht was paid for the laboratory. It is in the process that the network of Rajavithi Hospital and the pharmaceutical organization. Proceed to the drug plan. It will be available from the beginning of the 2019 fiscal year or from October 2018.
Source link
